0000899243-19-022590.txt : 20190829
0000899243-19-022590.hdr.sgml : 20190829
20190829195638
ACCESSION NUMBER: 0000899243-19-022590
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190827
FILED AS OF DATE: 20190829
DATE AS OF CHANGE: 20190829
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROEDER DOUGLAS A
CENTRAL INDEX KEY: 0001270735
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36189
FILM NUMBER: 191067600
MAIL ADDRESS:
STREET 1: 160 BOVET RD, SUITE 408
STREET 2: C/O DELPHI VENTURES
CITY: SAN MATEO
STATE: CA
ZIP: 94402
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC
CENTRAL INDEX KEY: 0001438133
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204327508
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11075 ROSELLE STREET
CITY: San Diego
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-366-6900
MAIL ADDRESS:
STREET 1: 11075 ROSELLE STREET
CITY: San Diego
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-08-27
0
0001438133
TANDEM DIABETES CARE INC
TNDM
0001270735
ROEDER DOUGLAS A
C/O DELPHI VENTURES,
63 BOVET ROAD, SUITE 351
SAN MATEO
CA
94402
1
0
0
0
Common Stock
2019-08-27
4
S
0
122018
70.0969
D
1173628
I
See Footnote
Common Stock
2019-08-27
4
S
0
1191
70.0969
D
11460
I
See Footnote
Common Stock
2019-08-28
4
S
0
166704
70.4211
D
1006924
I
See Footnote
Common Stock
2019-08-28
4
S
0
1628
70.4211
D
9832
I
See Footnote
Common Stock
2019-08-28
4
S
0
16594
71.0004
D
990330
I
See Footnote
Common Stock
2019-08-28
4
S
0
162
71.0004
D
9670
I
See Footnote
This transaction was effected pursuant to a Rule 10b5-1 trading plan entered into on May 14, 2019.
This transaction was executed in multiple trades at prices ranging from $70.00 to $70.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $70.00 to $70.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $71.00 to $71.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The Reporting Person is a managing member of Delphi Management Partners VIII, L.L.C. ("DMP"), the general partner of Delphi Ventures VIII, L.P. As a managing member of DMP, the Reporting Person shares voting and investment power over the securities held by Delphi Ventures VIII, L.P. and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Delphi Ventures VIII, L.P., except to the extent of his proportionate pecuniary interest therein.
The Reporting Person is a managing member of Delphi Management Partners VIII, L.L.C. ("DMP"), the general partner of Delphi BioInvestments VIII, L.P. As a managing member of DMP, the Reporting Person shares voting and investment power over the securities held by Delphi BioInvestments VIII, L.P. and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Delphi BioInvestments VIII, L.P., except to the extent of his proportionate pecuniary interest therein.
/s/ Matthew T. Potter, by power of attorney for Douglass A. Roeder
2019-08-29